NCT03160040View on ClinicalTrials.gov

A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

October 11, 2017

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions
Gram-Negative Bacterial Infections
Interventions
DRUG

Minocycline IV

This study is an observational study. All participants were administered minocycline IV prior to enrollment in this study.

Trial Locations (6)

11219

Maimonides Medical Center, Brooklyn

32803

Florida Hospital Orlando, Orlando

33901

Lee Memorial Health System, Fort Myers

77901

Infectious Disease and Pulmonary Consultant, Victoria

84132

University of Utah Health Sciences Center, Salt Lake City

89102

University Medical Center of Southern Nevada, Las Vegas

All Listed Sponsors
lead

Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

INDUSTRY

NCT03160040 - A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting | Biotech Hunter | Biotech Hunter